A paper on biotechnology and bioethics

Faculty Health law is a broad and exciting field that is not easily defined. There are, at least, three different, but overlapping, components to health law.

A paper on biotechnology and bioethics

Saint Mary's University The stakeholder concept is one of the most attractive conceptual devices in business ethics. A paper on biotechnology and bioethics concept has its origins in a theory of management, but has been seized upon by scholars in business ethics as a way of expressing the idea that businesses have obligations to a wide range of parties, beyond the stockholders to whom corporate heads were traditionally thought to be beholden.

It involves a reinterpretation of the social role of business, and a move away from the view, famously advocated by economist Milton Friedman, that the only proper function of corporate leaders is to increase the wealth of stockholders.

The stakeholder concept, whatever its weaknesses, gives due credit to the fact that the motives of agents involved in business are relatively complex. The conflict between those varied motives has been a central theme in the business ethics literature.

Freeman includes in his list of stakeholders suppliers, customers, employees, stockholders, and the firm's local community. This list, though typical of the lists given by stakeholder theorists, is not uncontroversial.

Indeed, the stakeholder concept itself has its critics. Those critics charge that the stakeholder approach is incapable of guiding necessary improvements in corporate governance,3 that the multiple lines of accountability implied by acknowledging a multiplicity of stakeholders reduces efficiency,4 and that indeed the very idea of stakeholders as morally significant undermines the morally significant relationship between corporate executives and stockholders.

In particular, the process known as "stakeholder analysis" can provide biotechnology companies with a lens through which to pay attention to the full range of interested parties. Stakeholder theory suggests that we should pay attention to the interests of any group or individual who is affected by, or who may affect, a decision or policy.

A rich body of literature exists on the extent to which the interests of various stakeholders should be integrated into corporate decision-making, and ways in which that can be accomplished. Nor will I stake a claim on the critical question of whether those stakeholders deemed relevant should merely have their wishes or needs accounted for, or whether they should instead be consulted directly.

I will simply suggest that the concept of a stakeholder, and the understanding that a very wide range of individuals and groups have a stake in the workings of a given company, can serve as a focal point for discussing what obligations a company has, and to whom.

Stakeholder analysis, in practice, is a relatively complex process, aimed at "identifying and understanding multiple often competing political, social, legal, economic, and moral claims of many constituencies.

The first, descriptive phase of the analysis would begin with listing the range of parties having a stake in the issue. All of these parties, and perhaps others, can be said to have a stake in the benefit sharing practices of a particular corporation.

The next step in this descriptive process would be to assess the nature of each stakeholder's interest in this issue, perhaps categorizing such interests as ethical, political, economic, legal, and so on. The second, normative phase of the stakeholder analysis would include an assessment of the kinds and degrees of obligation that the corporation has to each stakeholder.

With regard to some stakeholders, for example, the obligations will be written, contractual obligations. With regard to other stakeholders, they will be what are known as "fiduciary," or trust-based, obligations.

Other stakeholder obligations might be grounded in theories of what good neighbours owe each other. In other cases, the conclusion may be that a particular stakeholder is owed no obligations at all.

There is no straightforward, uncontroversial algorithm for determining the nature and extent of obligations to various stakeholders. The point here, however, is not to settle upon a canonical rank-ordering of the corporation's obligations to various stakeholders, but rather to accurately situate the corporation as enmeshed in a range of ethically significant relationships, and to begin the complex task of meeting the demands of those various relationships.

The stakeholder concept has, of course, already played a role in discussions related to biotech benefit sharing. For example, both the World Bank8 and the World Intellectual Property Organization9 have made use of the concept in discussion documents.

But the use of the stakeholder concept in such discussions has occurred in relative isolation from the rich literature that exists concerning the plausibility and application of that concept.

A more well-informed application of the concept is required. Business Ethics and Stakeholder Analysis. Business Ethics Quarterly, 1: A Stakeholder Theory of the Modern Corporation.

Accountability in the Marketplace. Institute of Economic Affairs.Digital Impact LLC produces large format, high-resolution, semi-permanent corrugated/mixed material POP & POS displays, product packaging and specialized permanent displays for companies of all backgrounds.

Our clients know us for our reliability, speed to market, and long-standing razor sharp focus on customer service. Utilizing state of the art digital printing, we produce product packaging. Sessions & Tracks.

A paper on biotechnology and bioethics

Track 1: Medicine & Biotechnology. From manipulation of mutant genes to enhanced resistance to disease, biotechnology has allowed advances in medicine. Biotechnology is used in medicinal field such as Pharmacogenomics, Genetic Diagnosis and Gene leslutinsduphoenix.com study of pharmacogenomics can result in the development of tailor-made vaccines for people, more accurate .

Learning About Myotonic Dystrophy. What is myotonic dystrophy? What are the symptoms of myotonic dystrophy? How is myotonic dystrophy diagnosed? What is the treatment for myotonic dystrophy? A POWERFUL NEW technique for editing genomes, CRISPR-Cas9, is the latest in a series of advances in biotechnology that have raised concerns about the ethics of biomedical research and inspired.

Apr 13,  · Bioethics Essay; Bioethics Essay. Med Tech Laws and Bioethics. Words | 17 Pages. PROFESSIONAL REGULATION COMMISSION What is PD ?

(Biotechnology and Bioethics). Embryonic stem cell research is the study of a tiny cell, taken from an embryo, which during the development of the embryo grows into many different organ or tissue cells. Bioethics; Bioethics Resources; Thinking Ethically About Human Biotechnology ; Margaret R.

McLean, Ph.D. Modern biotechnology, with its focus on molecular biology and its concern for increasing human health and life spans, is all about the future. This biotech future presses in daily, sparking imaginations. At the same time, it elicits wariness.

Global catastrophic risk - Wikipedia